Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Health Insurance Innovations (HIIQ) PT Raised to $55 at Canaccord Genuity
-
Teligent (TLGT) PT Lowered to $3.50 at Canaccord Genuity
-
Splunk (SPLK) PT Raised to $110 at Canaccord Genuity
-
Tyme Technologies Announces Pricing of its Offering of 9 Million Shares of Common Stock
-
Tyme Technologies Announces Pricing of its Offering of 9 Million Shares of Common Stock
-
Integra Resources Announces Appointments of Timo Jauristo and George Salamis to Its Board of Directors
-
ATARA Biotherapeutics (ATRA) Prices 4.286M Common Share Offering at $35/Sh
-
salesforce.com (CRM) PT Raised to $135 at Canaccord Genuity
-
STAAR Surgical (STAA) PT Raised to $21 at Canaccord Genuity
-
Darling International (DAR) PT Raised to $21 at Canaccord Genuity
-
Ducommun Incorporated (DCO) PT Lowered to $36 at Canaccord Genuity
-
Heska Corp. (HSKA) PT Lowered to $95 at Canaccord Genuity
-
Merit Medical Systems, Inc. (MMSI) PT Raised to $57 at Canaccord Genuity
-
Envision Healthcare (EVHC) PT Raised to $46 at Canaccord Genuity
-
Atara Biotherapeutics Announces Pricing of Public Offering of Common Stock
-
Atara Biotherapeutics Announces Pricing of Public Offering of Common Stock
-
Livanova (LIVN) PT Raised to $83 at Canaccord Genuity
-
HEICO (HEI) PT Raised to $100 at Canaccord Genuity, 'FY18 upside greater than expected'
-
Kratos Executes Definitive Agreement to Sell Public Safety & Security Division to Securitas Electronic Security, Inc. for Expected Net Proceeds of Approximately $70 Million
-
AxoGen, Inc. Reports 2017 Fourth Quarter and Full Year Financial Results
-
AxoGen, Inc. Reports 2017 Fourth Quarter and Full Year Financial Results
-
MasTec (MTZ) PT Raised to $65 at Canaccord Genuity; Sees More Upside
-
Veeva Systems (VEEV) PT Raised to $75 at Canaccord Genuity on 4Q Report; 'Upside Results and Solid Guide'
-
Filo Mining Announces Closing of C$25.5 Million Financing
-
Evolent Health (EVH) PT Lowered to $24 at Canaccord Genuity
-
GenMark Diagnostics (GNMK) PT Lowered to $8 at Canaccord Genuity
-
Penumbra (PEN) PT Raised to $125 at Canaccord Genuity
-
Steven Madden (SHOO) PT Raised to $52 at Canaccord Genuity
-
Laboratory Corporation of America (LH) PT Raised to $195 at Canaccord Genuity
-
K2M Group Holdings, Inc. to Participate in Four Investor Conferences in March
-
K2M Group Holdings, Inc. to Participate in Four Investor Conferences in March
-
Misonix to Present at the 13th Annual Canaccord Genuity Musculoskeletal Conference on March 6
-
Astronics (ATRO) PT Raised to $50 at Canaccord Genuity; 'Strong backlog offsets margin concerns'
-
Canaccord Genuity Upgrades Itron (ITRI) to Buy
-
Canaccord Genuity Downgrades Badger Meter (BMI) to Sell
-
HMS Holdings (HMSY) PT Raised to $20 at Canaccord Genuity; '2018 guidance based on higher visibility'
-
AtriCure Inc. (ATRC) PT Raised to $26 at Canaccord Genuity
-
Tactile Systems Technology (TCMD) PT Raised to $42 at Canaccord Genuity
-
Livanova (LIVN) PT Raised to $81 at Canaccord Genuity
-
NuVasive (NUVA) PT Lowered to $73 at Canaccord Genuity
-
Tyme Inc. (TYME) Announces 12M Share Common Offering
-
Tyme Technologies Announces Offering of Common Stock
-
Tyme Technologies Announces Offering of Common Stock
-
Hibbett Sports (HIBB) PT Raised to $31 at Canaccord Genuity
-
Vericel to Present at the 13th Annual Canaccord Genuity Musculoskeletal Conference
-
Vericel to Present at the 13th Annual Canaccord Genuity Musculoskeletal Conference
-
Valeant Pharmaceuticals (VRX) PT Raised to $18 at Canaccord Genuity
-
SolarEdge Technologies (SEDG): Raising PT After Non Deal Roadshow - Canaccord
-
Kempharm (KMPH) PT Raised to $11 at Canaccord Genuity
-
Voyager Therapeutics (VYGR) PT Raised to $36 at Canaccord Genuity


